Objective: We investigated the role of dietary n-3 polyunsaturated fatty acids (n-3 PUFA) in the modulation of total antioxidant status in streptozotocin (STZ)-induced diabetic rats and their macrosomic offspring. Design: Female wistar rats, fed on control diet or n-3 PUFA diet, were rendered diabetic by administration of five mild doses of STZ on day 5 and were killed on days 12 and 21 of gestation. The macrosomic (MAC) pups were killed at the age of 60 and 90 days. Measurements: Lipid peroxidation was measured as the concentrations of plasma thiobarbituric acid reactive substances (TBARS), and the total antioxidant status was determined by measuring (i) plasma oxygen radical absorbance capacity (ORAC), (ii) plasma vitamin A, E and C concentrations, and (iii) antioxidant enzymes activities in erythrocytes. The plasma lipid concentrations and fatty acid composition were also determined. Results: Diabetes increased plasma triglyceride and cholesterol concentrations, whereas macrosomia was associated with enhanced plasma cholesterol and triglyceride levels, which diminished by feeding n-3 PUFA diet. N-3 PUFA diet also reduced increased plasma TBARS and corrected the decreased ORAC values in diabetic rats and their macrosomic offspring. EPAX diet increased the diminished vitamin A levels in diabetic mothers and vitamin C concentrations in macrosomic pups. Also, this diet improved the decreased erythrocyte superoxide dismutase and glutathione peroxidase activities in diabetic and macrosomic animals. Conclusion: Diabetes and macrosomia were associated with altered lipid metabolism, antioxidant enzyme activities and vitamin concentrations. N-3 PUFA diet improved hyperlipidemia and restored antioxidant status in diabetic dams and MAC offspring.
Introduction
Epidemiological studies have established that individuals with diabetes have a high risk of developing atherosclerotic vascular disease. 1 One of the earliest abnormalities observed in diabetic subjects is the involvement of oxidative stress. 2 Moreover, fetuses from mothers with gestational diabetes are at increased risk of developing fetal macrosomia, platelet hyperaggregability and oxidative stress. 3 High blood glucose levels in these newborns induce oxidative stress, 3 which, in turn, induces the production of highly reactive oxygen radicals, being toxic to cells, particularly to the plasma membranes where these radicals interact with the lipid bilayer. Endogenous antioxidant enzymes (e.g. superoxide dismutase, catalase, glutathione peroxidase and reductase) and vitamins are responsible for the detoxification of deleterious oxygen radicals. 4 In diabetes as well as in macrosomia, protein glycation and glucose autoxidation may generate free radicals, which, in turn, catalyze lipid peroxidation. 5 Moreover, disturbances in the antioxidant defense system in diabetes and macrosomia have been reported as follows: alteration in antioxidant enzymes activities, 6 impaired glutathione metabolism 7 and decreased ascorbic acid levels. 8 Treatment with antioxidants may prevent or reverse abnormalities associated with diabetes and its complications. Many studies have reported that dietary supplements by vitamins and minerals prevent or, at least, attenuate the organic deterioration, caused by an excessive oxidative stress in diabetics. 9, 10 Contradictory results have been reported on n-3 PUFA consumption and lipid peroxidation, measured as thiobarbituric acid reactive substance (TBARS) levels. In fact, Wander et al. 11 and Allard et al. 12 have reported increased levels of TBARS in human plasma after consumption of n-3 fatty acids (EPA and DHA), whereas Nordoy et al. 13 and Ando et al. 14 could not find any significant differences in TBARS levels in their studies. However, several reports have shown the beneficial effects of fish oils containing n-3 polyunsaturated fatty acids (PUFAs) like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the protection against lipid peroxidation in rat and human beings with diabetes. 15, 16 Owing to these beneficial effects of n-3 PUFA, we tested the hypothesis whether EPA and DHA are implicated in prevention and protection against free radical production or oxidative stress associated with lipid peroxidation in diabetes. To our knowledge, no studies have directly investigated the role of EPA and DHA in lipid metabolism and oxidative stress in macrosomia. Therefore, the present study was undertaken to assess the effects of a diet supplemented with n-3 fatty acids on total antioxidant status and lipid metabolism in diabetic rats and their obese offspring.
Materials and methods

Animals and diets
Female Wistar rats, 2-3 months old and weighing 200-250 g, were obtained from IFA-CREDO (Abresle, France). After 1 week of acclimation, animals were divided into two diet groups. The first group of rats was fed a control diet containing vegetable oil (ISIO oil) and the other group was fed an EPAX diet (containing EPA and DHA) for 15 days before mating. The chemical composition of the control diet was as follows (g/kg dry diet): starch, 587; casein, 200; cellulose, 50; sucrose, 50; mineral mix, 40; vitamin mix, 20; DL-methionine, 3; vegetable oil Isio-4 (Lesieur, Neuilly-sur-Seine, France), 50. Total oil comprised 5% of the diet. [17] [18] [19] [20] [21] In the EPAX diet, half of the vegetable oil Isio-4 was replaced by EPAX-7010. The composition of the mineral and the vitamin mix was identical to that described by Triboulot et al. 17 Isio-4 oil contained in mg/g, 47.2, 18 : 2 (n-6), 1.7, total (n-3) and 40.2, monounsaturated fatty acids (largely 18 : 1). EPAX-7010, in the form of ethyl ester, contained approximately 85% (n-3) PUFA, that is, EPA 70%, DHA, 12%, and atocopherol, 2.1-3.2%. It means that EPAX oil comprised 2.5% of the diet. As the n-3 PUFA consisted of 85% of the 2.5% EPAX oil, the total n-3 PUFA represented only 2.1% of the total diet. The quantity of a-tocopherol provided to the EPAX diet by the EPAX oil was negligible (0.05-0.08% of total diet). The details of the fatty acid composition of the control diet and the EPAX diet are presented in Table 1 . EPAX-7010 was tightly sealed under a stream of nitrogen to avoid lipid oxidation and kept at 41C. Diets were prepared every day and the rats consumed them ad libitum. Uneaten food was discarded; food cups and water bottles were washed frequently. Rats were housed individually in stainless-steel cages in a room maintained at 221C with a 12-h light-dark cycle.
Animal treatment by streptozotocin
In each diet group, a total of 25 pregnant rats were rendered diabetic by intraperitoneal (i.p.) injection of streptozotocin (40 mg/kg body weight) in 0.1 M citrate buffer, pH 4.5, on the fifth day of gestation. In each diet group, 10 pregnant dams were injected with citrate buffer alone as a control group. To follow the hyperglycemia during gestation, maternal blood was collected on days 12 and day 17 of gestation, for determining plasma glucose concentrations, by cutting off the tip of the tail and squeezing it gently. Glycemia was measured in pregnant rats by One Touch II s Glucometer (LifeScan, Johnson and Johnson, USA). All diabetic dams included in the study had the fasting blood glucose above 5.55 mM on both occasions. The success rate in obtaining these hyperglycemic dams in the current series was 60% (15 rats out of 25 streptozotocin-treated rats). The protocol of selection of macrosomic offspring has been well described elsewhere. 22 A total of 125 pups from the 15 streptozotocintreated dams and 91 pups from the 10 control dams were delivered at day 21. Pups, from the streptozotocin-treated dams, whose birth weights were 1.7 s.d. greater than the mean birth weight of the control pups, were classified as Fatty acids in diabetes and macrosomia A Yessoufou et al macrosomic or obese. The mean birth weight of the control pups was 5.9070.39 g. Therefore, experimental pups with birth weight 46.56 g were considered as macrosomic and included in the study. These obese pups were hyperglycemic and hyperinsulinemic. The non-macrosomic offspring of diabetic mothers were excluded, as maternal diabetes related to fetal macrosomia was the criterion for the selection of our experimental population. However, these normal-sized offspring of diabetic mothers were not hyperglycemic and hyperinsulinemic at birth. They had normal growth rates and did not show any significant difference from controls in serum lipids. At 4 weeks of age, pups of each group of rats were weaned and fed the control or EPAX diet for 3 months with respect to their respective maternal diet. At each experimental point, that is, days 60 and 90, 40 macrosomic or/and 40 control rats belonging to the control diet and EPAX diet group were anaesthetized with pentobarbital (60 mg/kg body weight) and killed, and blood and plasma were collected as described below. Only the male macrosomic offspring were included in the study.
The general guidelines for the care and use of laboratory animals, recommended by the council of European Economic Communities, were followed.
Blood samples
After overnight fasting, in each diet group and at each experimental point, that is, day 12 of gestation and day 21 at delivery, half of the pregnant dams (controls and steptozotocin-treated) were anaesthetized with pentobarbital (60 mg/kg body weight) and then bled from the abdominal aorta. Serum was obtained by low-speed centrifugation (1000 g Â 20 min) and preserved with 0.26 mM EDTA and 3 mM sodium azide. Plasma was immediately used for glucose, lipid, oxygen radical absorbance capacity (ORAC) and vitamin determinations. After removal of plasma, erythrocytes were washed three times with two volumes of isotonic saline solution. Erythrocytes were lysed with cold distilled water (1/4), stored in the refrigerator at 41C for 15 min and the cell debris was removed by centrifugation (2000 g Â 15 min). Erythrocyte lysates were assayed for antioxidant enzyme activities.
Determination of lipids and thiobarbituric acid-reactive substances (TBARS) Plasma triglyceride, phospholipid and total cholesterol concentrations were determined using enzymatic methods, according to the instructions furnished along with the kit (Boehringer, Mannheim, Germany). Plasma lipids were extracted according to the method of Bligh and Dyer, 23 then transmethylated by BF3/methanol after saponification, and fatty acids were analyzed by gas liquid chromatography. 24 Plasma free radical damage was determined by specifically measuring TBARS in plasma. 25 Scavenging capacity of plasma The ORAC of plasma was measured according to Cao et al.
26
A fluorescent protein b-allophycocyanin (APC) was used in this assay. 27 ORAC refers to the capacity of plasma to scavenge free radicals, and then to delay the loss of APC fluorescence. The reaction mixture (2 ml) in the assay contained a final concentration of 76.8 nM APC in 75 mM phosphate buffer pH 7.0, at 371C, 9 mM of Cu 2 þ (CuSO 4 ) and 0.3% H 2 O 2 , in the absence (blank) or the presence, respectively, of 20 ml of Trolox 1 mM (standard) or plasma (sample). Samples containing APC alone (blank) were prepared to monitor the spontaneous decay of fluorescence under experimental conditions. All readings were automatically corrected for the time-dependent decay. The APC fluorescence, at excitation 598 nm and emission 651 nm, was measured every 5 min, at 371C, using a spectrofluorometer (SFM25 Kontron Instrument, France) until the disappearance of fluorescence. The ORAC value of each plasma sample was calculated by measuring the net protection area under the quenching curve of APC. One ORAC unit has been assigned as the net protection area provided by 1 mM of Trolox. The ORAC value of the samples was calculated as ORAC ¼ (Asamples-Ablank)/(Atrolox-Ablank), A refers to the area under the quenching curve of APC.
Determination of plasma vitamin C levels
Vitamin C levels were determined in plasma using the method of Roe and Kuether. 28 After protein precipitation with 10% trichloroacetic acid and centrifugation, the supernatant (500 ml) was mixed with 100 ml of DTC reagent (9 N sulfuric acid containing 2,4-dinitrophenylhydrazine 3%, thiourea 0.4% and copper sulfate 0.05%) and incubated at 371C for 3 h. After the addition of 750 ml of 65% (v/v) sulfuric acid, the absorbency was recorded at 520 nm.
Determination of vitamin A and E levels in plasma
Plasma a-tocopherol (vitamin E) and retinol (vitamin A) were determined by reverse phase HPLC. 29 The stationary phase constituted greffed silica (C18 column, HP ODS Hypersil C18; 200 mm Â 4.6 mm; Lara spiral, maintenance temperature of analytical column, 351C). The mobile phase was a mixture of methanol/water (98/2, v/v) at a flow rate of 1 ml/ min. Vitamins were extracted by hexane, dried under nitrogen and resuspended in methanol. The extracted vitamins were injected in the HPLC system. 29 The HPLC peaks were detected by a UV detector at 292 nm for vitamin E and at 325 nm for vitamin A. Representative chromatograms were obtained by injecting standard solutions.
Determinations of erythrocyte antioxidant enzyme activities
Glutathione peroxidase (GSH-Px EC 1.11.1.9) was assessed by the method described elsewhere, 30 using cumene hydroperoxide as substrate. One unit of glutathione peroxidase 
Results
Plasma glucose concentrations and body weight Streptozotocin-injected pregnant rats showed an intense hyperglycemia, whatever the diet fed (Table 2) . At birth, all the selected macrosomic pups were significantly intensely hyperglycemic compared to the control pups. This agerelated hyperglycemia increased at days 60 and 90 (Table 3a) . Feeding the EPAX diet did not significantly influence glycemia.
The mean birth weight of the control pups was 5.9070.39 g whereas that of the selected obese pups of the control-diet-fed diabetic mothers was 8.0970.49 g. The success rate in obtaining these obese pups was 64% (80 pups Table 2 Plasma glucose concentrations (mM) in diabetic and control rats Values are mean7s.d. Significant differences between STZ-induced diabetic rats and their corresponding controls are as follows: y Po0.05 (diabetes effect). Significant differences between EPAX-diet and control-diet-fed animals are as follows: *Po0.05 (dietary effect). Days 12 and 21 correspond, respectively, to the day 12 of the gestation and day 21 at delivery. 
(c) Evolution of the body weight (g) of the offspring Po0.05. Significant differences between EPAX-diet and control-diet-fed animals are as follows: *Po0.05 (dietary effect). Days 0, 60 and 90 correspond, respectively, to the birth, 2-month-old and 3-month-old offspring.
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A Yessoufou et al out of 125 pups of control-diet-fed diabetic dams). In contrast, the success rate of obese pups of EPAX-diet-fed diabetic mothers was 48% (61 pups out of 127). The consumption of the EPAX diet diminished the incidence of macrosomia from 64 to 48% (Table 3b ). This beneficial effect of the EPAX diet on the body weight of macrosomic offspring was also observed at days 60 and 90 (Table 3c ).
Plasma lipid concentrations
Diabetes induced an increase in total cholesterol levels in diabetic dams compared to control animals and its levels were significantly higher in offspring of diabetic dams compared to control offspring ( Table 4 ). The EPAX diet induced a significant decrease in total cholesterol in diabetic mothers as well as in macrosomic offspring. The offspring (day 60) of the control dams had a high level of cholesterol (2.60170.132 mM); however, this value remained significantly lower than that of the macrosomic offspring (3.78170.112 mM). Diabetes and macrosomia increased plasma triglyceride concentrations in control-diet-fed animals. The EPAX diet, compared to control diet, exerted a triglyceride-lowering action in diabetic mothers as well as in their obese offspring, irrespective of their age. Plasma phospholipid levels were not significantly changed in any of the groups.
Antioxidant enzyme activities
Diabetes mellitus diminished SOD activity in both mothers and their offspring ( Table 5 ). The EPAX diet induced a significant increase in SOD activity in control and diabetic mothers and also in their offspring. GSSG-Red activity was not significantly affected by diabetes mellitus at day 12 of gestation. However, from day 21 onwards, control-diet-fed diabetic dams showed lower GSSG-Red activity when compared to their controls. GSSGRed activity was diminished in control-diet-fed obese offspring, but was increased in EPAX-diet-fed-obese offspring compared to their corresponding controls. The EPAX diet induced a significant increase in the activity of this enzyme only in macrosomic pups (Table 5) .
Diabetes mellitus caused a significant decrease in GSH-Px activity in mothers and their offspring. EPAX diet induced a significant increase in the activity of this enzyme in diabetic mothers and their offspring (Table 5) . 
Total cholesterol (mmol/l) Values are mean7s.d. Significant differences between STZ-induced diabetic rats or macrosomic offspring and their corresponding controls are as follows: y Po0.05 (diabetes effect). Significant differences between EPAX-diet and control-diet-fed animals are as follows: *Po0.05 (dietary effect). Days 12 and 21 correspond, respectively, to the day 12 of the gestation and day 21 at delivery. Days 60 and 90 correspond, respectively, to 2-month-old and 3-month-old offspring.
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Total fatty acid compositions of plasma lipids In dams at day 21. In the plasma lipids of pregnant rats, no significant change was observed in the percentages of saturated fatty acids (SFA) between diabetics and controls; however, these percentages were significantly lower in the EPAX-diet-fed group than the control-diet-fed group. In the control-diet-fed group, the proportions of linoleic acid (LA, C18 : 2n-6) significantly increased in diabetic animals compared to controls, whereas those of arachidonic acid (AA) decreased. Feeding the EPAX diet induced increased levels of EPA and DHA, whereas the levels of AA decreased in the nondiabetic group and remained stable in the diabetic group (Table 6) .
In offspring at days 60 and 90. In the plasma lipids of offspring, there was no change in the proportions of SFA (16 : 0; 18 : 0) between obese and control offspring, irrespective of the diet. In the control-diet group, macrosomia was associated with an increased level of linoleic acid (18 : 2n-6) and a decreased level of AA (20 : 4n-6). EPAX diet consumption induced an increased level of EPA and DHA, and corrected the changes induced by diabetes in LA and AA proportions, particularly at day 90 (Table 7) .
Plasma TBARS
Diabetic rats and their offspring exhibited high plasma TBARS compared to control rats, irrespective of their age (Figure 1 ). Feeding EPAX diet significantly reduced the marked increases in TBARS induced by diabetes and macrosomia.
Plasma total antioxidant status
Compared with controls, ORAC was significantly low in diabetic rats and their macrosomic offspring (Figure 2 ). The EPAX diet induced a significant increase in ORAC values in diabetic dams and macrosomic offspring, irrespective of their age.
Plasma vitamin C concentrations
Plasma vitamin C levels were not altered in diabetic mothers (results not shown). However, macrosomic pups, fed on the control diet, had low levels of vitamin C compared with controls. Dietary EPAX enhanced and improved plasma vitamin C concentrations in this group up to the level of controls (Figure 3a) . 
Po0
.05 (diabetes effect). Significant differences between EPAX-diet and control-diet-fed animals are as follows: *Po0.05 (dietary effect). Days 12 and 21 correspond, respectively, to the day 12 of the gestation and day 21 at delivery. Days 60 and 90 correspond, respectively, to 2-month-old and 3-month-old offspring. SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; GSSG-Red, glutathione reductase.
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Plasma vitamin A and E concentrations
Plasma vitamin A concentrations, diminished in diabetic mothers, were normalized by feeding EPAX diet, irrespective of the gestational age (Figure 3b ). Compared to controls, macrosomic pups fed the control diet exhibited lowered plasma vitamin A concentrations at day 90 only. In this group, feeding EPAX diet enhanced and restored its concentrations (Figure 3c ). The levels of vitamin E were unaltered in diabetic and macrosomic animals. Similarly, feeding EPAX diet failed to influence plasmatic vitamin E levels (results not shown).
Discussion
In the present study, we investigated the role of n-3 PUFA (essentially EPA, DHA) on lipid metabolism and total antioxidant status in streptozotocin (STZ)-induced diabetic rats and in their macrosomic offspring. The administration of streptozotocin (STZ) to mice [33] [34] [35] and rats 36 represents a good model of diabetes development for several reasons: (i) islet lesions in this experimental model resemble those of human insulitis, 35 (ii) the animals used are normal and do not have underlying immune abnormalities like BB rat 37 and male macrosomic offspring for the study. Indeed, sex hormones have been associated with the prevalence, the susceptibility and the severity of autoimmune diseases. 40 Moreover, immune responses between male and female rats are not identical, 41 and the dietary EPA/DHA highly influences immune response. 20 Had we chosen the male and female progenies, our results would have overlapped.
We observed that macrosomic offspring of diabetic dams were hyperglycemic at birth and had accelerated growth compared to offspring of control rats -independently of maternal diet. 22 Feeding the n-3 PUFA diet significantly reduced the incidence of gestational diabetes on macrosomia by decreasing the rate of macrosomic pups at birth from 64 to 48%. However, n-3 PUFA diet had no effect on hyperglycemia of macrosomic offspring. Furthermore, diabetes in pregnant rats was associated with hypertriglyceridemia as reported by several investigators. 42, 43 Maternal diabetes mellitus also induced hypercholesterolemia and hypertriglyceridemia in obese offspring, and this observation corroborated our previous studies. 22, 24, 39 In the present study, we observed a high level of cholesterol in the offspring of the control group at day 60; however, this level remained significantly lower than that of macrosomic offspring. In fact, a significant age-related change in serum cholesterol concentration has been evoked, 44 and this can be explained by the existence of a compensatory mechanism for maintenance of hepatic cholesterol homeostasis with age. 45 It has been shown that, in diabetic rats, high levels of triglyceride in maternal circulation may create a steep concentration gradient across the placenta, which accelerates their transport and deposition in fetal tissues. 43 This hypertriglyceridemia has been shown to persist with age and has been linked to the development of insulin sensitivity and hyperlipogenesis. 46 Feeding EPAX diet significantly 
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A Yessoufou et al decreased triglyceride and cholesterol concentrations in diabetic rats. EPAX diet attenuated hyperlipidemia, a longterm complication of macrosomia, in offspring of diabetic dams. This observation is in accordance with previous findings, which have shown that n-3 PUFA-enriched diets decrease both plasma triglyceride and cholesterol levels. 47 Diabetic rats and their macrosomic offspring exhibited a significant increase in plasma TBARS. In our study, a significant decrease was observed in TBARS after feeding n-3 PUFA to the diabetic rats and their obese offspring. These findings are substantiated by several investigators 48, 49 who have reported a decreased production of TBARS in human subjects treated with DHA and EPA. In fact, endogenous antioxidant enzymes and vitamins are responsible for the detoxification of deleterious oxygen radicals. 4 Diabetes, in our study, leads to a significant decrease in the plasma total antioxidant status as measured by diminished ORAC in rats fed on the control diet. Several authors, including McLennan et al. 7 and Young et al. 8 have also demonstrated diminished antioxidant enzyme activities and vitamin levels in STZinduced diabetic rats. Similarly, macrosomic pups exhibited diminished plasma ORAC, vitamin C concentrations, SOD and GSH-Px activities. Similar results have been obtained by Dincer et al. 6 who have shown a decrease in these enzyme activities in the liver and lung of neonate STZ-induced diabetic rats. In the present study, we have observed that feeding EPAX diet reduces the oxidative stress, induced by diabetes and macrosomia. The EPAX diet also corrected plasma ORAC levels in diabetic rats and macrosomic pups. This could be related to increased plasma vitamin A levels and improved erythrocyte antioxidant enzyme activities.
Our results are consistent with other reports on the reduction of lipid peroxidation and an improvement in the activities of antioxidant enzymes with n-3 PUFA in human beings and animals with experimental diabetes.
15,21,50-52
Alpha-tocopherol is known as a liposoluble antioxidant molecule. In the EPAX diet, its quantity was very negligible (0.05-0.08%). The antioxidant properties cannot be solely contributed by alpha-tocopherol as it was present in both standard and experimental diets. However, the antioxidant properties might have principally been contributed by EPA or DHA as these fatty acids were abundantly present in the experimental diet. EPA and DHA belong to the same family of fatty acids as they are derived from the same precursor. As the EPAX oil is rich in EPA, we can assume that this fatty acid may largely contribute to the antioxidant properties in our study. However, the general notion is that n-3 PUFA might deteriorate antioxidant capacity. Nonetheless, no consensus has been reached on this subject as shown in Table 7 . Excess intake of n-3 PUFA may reduce antioxidant status, 11, 12, 50, 53, 54 thus enhancing susceptibility to oxidative damage. Other investigators 13, 14, 55 could not find any change in antioxidant status in humans and rats treated with n-3 fatty acid-rich diet. On the contrary, Kesavulu et al. 51 have demonstrated that the treatment of diabetic patients with n-3 fatty acids improved their antioxidant status. In our study, a significant improvement was also observed in antioxidant status in n-3 PUFA-fed diabetic rats and their obese offspring. It has been shown that dietary fish oil alters the composition of plasma membrane phospholipids by increasing EPA and DHA contents at the expense of AA levels. 14 This substitution may diminish or counterbalance the negative effects of AA (n-6 PUFA) on antioxidant status. The balance between n-3 and n-6 fatty acids may markedly affect cell metabolism. y Po0.05 and yy Po0.01. Significant differences between EPAX-diet and control-diet-fed animals are as follows: * Po0.05 and **Po0.01. Days 12 and 21 correspond, respectively, to day 12 of gestation and day 21 at delivery. Days 60 and 90 correspond, respectively, to 2-month-old and 3-month-old offspring.
Fatty acids in diabetes and macrosomia A Yessoufou et al Indeed, essential fatty acids pattern influences the physical properties of cell membranes (fluidity and permeability), the activity of membrane receptors, enzymes and ion channels and cell response to various stimuli through the production of secondary messengers. Hence, the beneficial effect of EPAX diet on antioxidant status will involve DHA and EPA. In addition, EPA is known to give rise to eicosanoids of n-3 series, which exert opposite effects to those of n-6 series, derived from AA. Besides, EPA may also be converted into DHA, which along with dietary DHA, may further contribute to the beneficial effects. It has been recently shown that DHA may also give rise to some recently discovered derivatives like docosatrienes or resolvins, which also exert beneficial effects. 56 Besides, these fatty acids have been shown to modulate cell signaling mechanisms via their incorporation into the plasma membrane phospholipids. 57 Although the exact mechanism by which EPA/DHA exerted antioxidant action is not well understood, Das et al. 58 have suggested in their study that EPA/DHA supplementation inhibited free radical generation and suppressed lipid peroxidation and NO synthesis in patients with nephritic syndrome. This finding suggests that EPA or DHA may be involved in scavenging of free radicals and NO. Similarly, Yazu et al. 59 have reported that in aqueous, micellar dispersions composed of methyl esters of EPA or linoleate, the oxidizability of the methyl ester of EPA was lower than that of methyl linoleate. The EPA micelle had X2 molecules of oxygen in the peroxyl radical, whereas the linoleate micelle had only 1. These authors argued that the EPA was more polar than linoleate, and the polar radicals might migrate from the lipophilic core of the micelle to the polar surface. Owing to this migration, an environment was created that favored the termination and reduced the propagation of oxidation reactions. 11 This is one of the mechanisms which may explain that EPA possesses antioxidant properties and it behaves as a peroxyl and free radical scavenger; however, more studies are needed to elucidate the mechanism of action of DHA. An increase in the levels of plasma fatty acids, without dietary supplementation during normal pregnancy, has been reported. 60 Dunstan et al. 61 have observed that supplementing the diet with fish oil (EPA and DHA), during pregnancy, resulted in an increase in EPA and DHA in phospholipids of maternal peripheral blood at 30 and 37 weeks of gestation, and remained elevated at 6 weeks postpartum. However, in the present study, we have observed that the dietary supplementation with EPA and DHA prevented hyperlipidemia in diabetic pregnant mothers and macrosomic offspring. Our findings are in accordance with several studies which have reported that dietary n-3 PUFA might counteract maternal and fetal hypertriglyceridemia and might decrease weight gain associated with macrosomia. 16, 62 In our study, diabetes causes a major decline in plasma AA and an increase in LA concentrations in dams and their macrosomic offspring, and this may be due to an impaired activity of D 5 and D 6 desaturases. 63 The complications associated with diabetes, such as increased oxidative stress and hyperglycemia, could be related to this intense decline of plasma AA concentrations, as some studies have shown that AA may have a critical role in maintaining the appropriate mass and function of islet beta-cells by influencing rates of cell proliferation and insulin secretion. 64 The novel finding of our study is that a moderate n-3 PUFA diet improves antioxidant status in rats during diabetic pregnancy and their adult macrosomic offspring. In fact, macrosomia is a growing health problem all over the world. One of the causes of macrosomia is diabetic pregnancy. No study is available on the improvement of antioxidant status by moderate n-3 PUFA in these two pathologies. Our study adds another factor in the etiopathology of macrosomia and diabetic pregnancy. As feeding fish oil showed a beneficial effect by increasing the antioxidant defense system, we can allude that an adequate dose of fish oil may be recommended in foods to reduce the incidence and complications associated with macrosomia of diabetic pregnancy.
